SCHEMBL1086217

SCHEMBL1086217

COc1cccc(OC)c1P(CCCP(c1c(OC)cccc1OC)c1c(OC)cccc1OC)c1c(OC)cccc1OC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.47
CA1 P00915 4/20 0.44
CA2 P00918 4/20 0.44
CA7 P43166 3/20 0.44
CA9 Q16790 3/20 0.44
CA12 O43570 2/20 0.44
CA14 Q9ULX7 2/20 0.44
CA4 P22748 1/20 0.44
ALDH1A1 P00352 3/20 0.40
TP53 P04637 2/20 0.40
MAPK1 P28482 2/20 0.40
KDM4E B2RXH2 1/20 0.40
LMNA P02545 1/20 0.40
CYP3A4 P08684 1/20 0.40
MAPT P10636 1/20 0.40
HPGD P15428 1/20 0.40
ALOX15 P16050 1/20 0.40
ALOX12 P18054 1/20 0.40
HSD17B10 Q99714 1/20 0.40
ALOX5 P09917 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17529727 0.90 ALOX5 (0.45) SMN1; SMN2CA1CA2CA7CA9
SCHEMBL17529711 0.88 ALOX5 (0.47) SMN1; SMN2CA1CA2CA7CA9
SCHEMBL17529692 0.87 PPARA (0.48) SMN1; SMN2CA1CA2CA7CA9
SCHEMBL17529847 0.87 PPARA (0.48) SMN1; SMN2CA1CA2CA7CA9
SCHEMBL17529835 0.87 PPARA (0.48) SMN1; SMN2CA1CA2CA7CA9
SCHEMBL8677993 0.85 CA1 (0.42) SMN1; SMN2CA1CA2CA7CA9
SCHEMBL17529880 0.80 CA1 (0.46) SMN1; SMN2CA1CA2CA7CA9
SCHEMBL2332056 0.77 CA1 (0.48) SMN1; SMN2CA1CA2CA7CA9
SCHEMBL8208812 0.77 ALDH1A1 (0.40) SMN1; SMN2CA1CA2CA7CA9
SCHEMBL8780913 0.77 CA1 (0.42) SMN1; SMN2CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0788405-A1 CATALYST FOR THE PREPARATION OF LINEAR CARBON MONOXIDE/ALPHA-OLEFIN COPOLYMERS THE DOW CHEMICAL COMPANY (US) 1997-08-13 EP claimed
WO-1996001690-A1 CATALYST FOR THE PREPARATION OF LINEAR CARBON MONOXIDE/ALPHA-OLEFIN COPOLYMERS THE DOW CHEMICAL COMPANY (US) 1996-01-25 WO claimed
EP-0257663-B1 CATALYST COMPOSITIONS, OLEFIN/CO COPOLYMERIZATION PROCESS AND BISPHOSPHINE COMPOUNDS SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1992-01-15 EP claimed
EP-0257663-A2 Catalyst compositions, olefin/co copolymerization process and bisphosphine compounds SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1988-03-02 EP claimed
EP-2164831-B1 METHOD FOR THE PRODUCTION OF N-SUBSTITUTED (3-DIHALOMETHYL-1-METHYL-PYRAZOLE-4-YL) CARBOXAMIDES BASF SE (DE) 2013-07-17 EP disclosed
US-8153820-B2 Method for the production of N-substituted (3-dihalomethyl-1-methylpyrazol-4-yl) carboxamides BASF SE (DE) 2012-04-10 US disclosed
US-20100174094-A1 Method for the Production of N-Substituted (3-Dihalomethyl-1-Methyl-Pyrazole-4-yl) Carboxamides BASF SE (DE) 2010-07-08 US disclosed
EP-1475394-A2 Olefin polymerization process E.I. DU PONT DE NEMOURS AND COMPANY (US) 2004-11-10 EP disclosed
US-6103920-A Olefin polymerization process E. I. DU PONT DE NEMOURS AND COMPANY (US) 2000-08-15 US disclosed
EP-0650761-B1 Catalyst composition and process for the preparation of polymers SHELL INT RESEARCH (NL) 1999-01-13 EP disclosed
EP-0562698-B1 Novel olefin/CO copolymers SHELL INT RESEARCH (NL) 1997-09-24 EP disclosed
EP-0788405-A1 CATALYST FOR THE PREPARATION OF LINEAR CARBON MONOXIDE/ALPHA-OLEFIN COPOLYMERS THE DOW CHEMICAL COMPANY (US) 1997-08-13 EP disclosed
EP-0298540-A2 Preparation of phosphides SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1989-01-11 EP disclosed
EP-0285218-A2 Removal of catalyst remnants from olefin/CO copolymers SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1988-10-05 EP disclosed
EP-0283092-A1 Process for removing palladium catalyst remnants from copolymers of carbon monoxide with one or more olefinically unsaturated compounds SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1988-09-21 EP disclosed
EP-0272728-A2 Process for the preparation of polymers of C0 and olefinically unsaturated compounds SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1988-06-29 EP disclosed
EP-0272727-A2 Novel polymers of carbon monoxide and alpha-olefinically unsaturated compounds SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1988-06-29 EP disclosed
EP-0269154-A2 Novel olefin/CO copolymers SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1988-06-01 EP disclosed
EP-0263564-A1 Catalyst compositions and olefin/CO-copolymerization process SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1988-04-13 EP disclosed
EP-0257663-A2 Catalyst compositions, olefin/co copolymerization process and bisphosphine compounds SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1988-03-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100174094-A1 Method for the Production of N-Substituted (3-Dihalomethyl-1-Methyl-Pyrazole-4-yl) Carboxamides CBR3, CBR1, CYC1 SMN1; SMN2 3019/4885CA1 667/4885CA2 698/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.